nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000304	0.000304	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—HRAS—salivary gland cancer	0.000304	0.000304	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—WNT5B—salivary gland cancer	0.000302	0.000302	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MAML3—salivary gland cancer	0.000301	0.000301	CbGpPWpGaD
Naloxone—CREB1—Immune System—FGFR4—salivary gland cancer	0.0003	0.0003	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—PIK3CA—salivary gland cancer	0.000298	0.000298	CbGpPWpGaD
Naloxone—CREB1—Immune System—FBXW7—salivary gland cancer	0.000295	0.000295	CbGpPWpGaD
Naloxone—TLR4—Immune System—EP300—salivary gland cancer	0.000295	0.000295	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—TP53—salivary gland cancer	0.000294	0.000294	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000294	0.000294	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—CREBBP—salivary gland cancer	0.000294	0.000294	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IL17RD—salivary gland cancer	0.000292	0.000292	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—HRAS—salivary gland cancer	0.000288	0.000288	CbGpPWpGaD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—salivary gland cancer	0.000288	0.000288	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—TP53—salivary gland cancer	0.000283	0.000283	CbGpPWpGaD
Naloxone—CREB1—Transmission across Chemical Synapses—HRAS—salivary gland cancer	0.000282	0.000282	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.000281	0.000281	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.00028	0.00028	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ISYNA1—salivary gland cancer	0.00028	0.00028	CbGpPWpGaD
Naloxone—CREB1—Disease—JAG1—salivary gland cancer	0.000278	0.000278	CbGpPWpGaD
Naloxone—ALB—Metabolism—ISYNA1—salivary gland cancer	0.000278	0.000278	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—DTX4—salivary gland cancer	0.000278	0.000278	CbGpPWpGaD
Naloxone—CREB1—Disease—FGFR4—salivary gland cancer	0.000277	0.000277	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—HRAS—salivary gland cancer	0.000276	0.000276	CbGpPWpGaD
Naloxone—CREB1—Disease—FBXW7—salivary gland cancer	0.000273	0.000273	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MC3R—salivary gland cancer	0.000268	0.000268	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MAML3—salivary gland cancer	0.000267	0.000267	CbGpPWpGaD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—salivary gland cancer	0.000266	0.000266	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—FGF16—salivary gland cancer	0.000263	0.000263	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—FGF16—salivary gland cancer	0.000262	0.000262	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CREBBP—salivary gland cancer	0.000259	0.000259	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000258	0.000258	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000254	0.000254	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—NUP62—salivary gland cancer	0.000254	0.000254	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.00025	0.00025	CbGpPWpGaD
Naloxone—CREB1—Immune System—FOXO3—salivary gland cancer	0.000249	0.000249	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—PIK3CA—salivary gland cancer	0.000249	0.000249	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CDH1—salivary gland cancer	0.000247	0.000247	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—NUP62—salivary gland cancer	0.000244	0.000244	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ISYNA1—salivary gland cancer	0.000244	0.000244	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—TP53—salivary gland cancer	0.000242	0.000242	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—VCAN—salivary gland cancer	0.000242	0.000242	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MC3R—salivary gland cancer	0.000238	0.000238	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—DTX4—salivary gland cancer	0.000235	0.000235	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—HRAS—salivary gland cancer	0.00023	0.00023	CbGpPWpGaD
Naloxone—CREB1—Disease—FOXO3—salivary gland cancer	0.00023	0.00023	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—MAML2—salivary gland cancer	0.00023	0.00023	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—FGF16—salivary gland cancer	0.00023	0.00023	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000229	0.000229	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—PIK3CA—salivary gland cancer	0.000229	0.000229	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MAML2—salivary gland cancer	0.000228	0.000228	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—MARCKS—salivary gland cancer	0.000228	0.000228	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MAML2—salivary gland cancer	0.000227	0.000227	CbGpPWpGaD
Naloxone—ALB—Metabolism—MARCKS—salivary gland cancer	0.000227	0.000227	CbGpPWpGaD
Naloxone—ESR1—Generic Transcription Pathway—NOTCH1—salivary gland cancer	0.000225	0.000225	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000223	0.000223	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000223	0.000223	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000222	0.000222	CbGpPWpGaD
Naloxone—TLR4—Immune System—PIK3CA—salivary gland cancer	0.000218	0.000218	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.000218	0.000218	CbGpPWpGaD
Naloxone—CREB1—Neuronal System—HRAS—salivary gland cancer	0.000216	0.000216	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—SMC1A—salivary gland cancer	0.000212	0.000212	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000212	0.000212	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PYGB—salivary gland cancer	0.000212	0.000212	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—HRAS—salivary gland cancer	0.000212	0.000212	CbGpPWpGaD
Naloxone—ALB—Metabolism—PYGB—salivary gland cancer	0.000211	0.000211	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—DTX4—salivary gland cancer	0.000208	0.000208	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000207	0.000207	CbGpPWpGaD
Naloxone—ESR1—Generic Transcription Pathway—CREBBP—salivary gland cancer	0.000204	0.000204	CbGpPWpGaD
Naloxone—CREB1—Immune System—MAP2K2—salivary gland cancer	0.000203	0.000203	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000202	0.000202	CbGpPWpGaD
Naloxone—TLR4—Immune System—HRAS—salivary gland cancer	0.000202	0.000202	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.0002	0.0002	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—EP300—salivary gland cancer	0.0002	0.0002	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MAML2—salivary gland cancer	0.000199	0.000199	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—MARCKS—salivary gland cancer	0.000199	0.000199	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—JAG1—salivary gland cancer	0.000195	0.000195	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000195	0.000195	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—JAG1—salivary gland cancer	0.000194	0.000194	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—FGF16—salivary gland cancer	0.000194	0.000194	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—FGFR4—salivary gland cancer	0.000194	0.000194	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—FGFR4—salivary gland cancer	0.000193	0.000193	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—HRAS—salivary gland cancer	0.000192	0.000192	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—FBXW7—salivary gland cancer	0.000191	0.000191	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—FBXW7—salivary gland cancer	0.00019	0.00019	CbGpPWpGaD
Naloxone—CREB1—Disease—MAP2K2—salivary gland cancer	0.000188	0.000188	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—PTEN—salivary gland cancer	0.000185	0.000185	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PYGB—salivary gland cancer	0.000185	0.000185	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—PTEN—salivary gland cancer	0.000178	0.000178	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—EP300—salivary gland cancer	0.000177	0.000177	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PHGDH—salivary gland cancer	0.000173	0.000173	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—FGF16—salivary gland cancer	0.000172	0.000172	CbGpPWpGaD
Naloxone—ALB—Metabolism—PHGDH—salivary gland cancer	0.000172	0.000172	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—JAG1—salivary gland cancer	0.00017	0.00017	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—FGFR4—salivary gland cancer	0.00017	0.00017	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MAML2—salivary gland cancer	0.000169	0.000169	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—FBXW7—salivary gland cancer	0.000167	0.000167	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ST3GAL4—salivary gland cancer	0.000166	0.000166	CbGpPWpGaD
Naloxone—ALB—Metabolism—ST3GAL4—salivary gland cancer	0.000165	0.000165	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000164	0.000164	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000161	0.000161	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—FOXO3—salivary gland cancer	0.000161	0.000161	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—FOXO3—salivary gland cancer	0.00016	0.00016	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000155	0.000155	CbGpPWpGaD
Naloxone—CREB1—Disease—NOTCH1—salivary gland cancer	0.000154	0.000154	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000152	0.000152	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—AQP1—salivary gland cancer	0.000151	0.000151	CbGpPWpGaD
Naloxone—CREB1—Immune System—CREBBP—salivary gland cancer	0.000151	0.000151	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PHGDH—salivary gland cancer	0.000151	0.000151	CbGpPWpGaD
Naloxone—ALB—Metabolism—AQP1—salivary gland cancer	0.00015	0.00015	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	0.00015	0.00015	CbGpPWpGaD
Naloxone—CREB1—Immune System—CDH1—salivary gland cancer	0.00015	0.00015	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MAML2—salivary gland cancer	0.000149	0.000149	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000148	0.000148	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ST3GAL4—salivary gland cancer	0.000145	0.000145	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000145	0.000145	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—JAG1—salivary gland cancer	0.000144	0.000144	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—FGFR4—salivary gland cancer	0.000143	0.000143	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—FBXW7—salivary gland cancer	0.000141	0.000141	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—FOXO3—salivary gland cancer	0.000141	0.000141	CbGpPWpGaD
Naloxone—CREB1—Disease—CREBBP—salivary gland cancer	0.000139	0.000139	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—HRAS—salivary gland cancer	0.000137	0.000137	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—AQP1—salivary gland cancer	0.000132	0.000132	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MAP2K2—salivary gland cancer	0.000131	0.000131	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MAP2K2—salivary gland cancer	0.000131	0.000131	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—PIK3CA—salivary gland cancer	0.000131	0.000131	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—JAG1—salivary gland cancer	0.000128	0.000128	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—FGFR4—salivary gland cancer	0.000127	0.000127	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—PIK3CA—salivary gland cancer	0.000125	0.000125	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—FBXW7—salivary gland cancer	0.000125	0.000125	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—MARCKS—salivary gland cancer	0.000122	0.000122	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—HRAS—salivary gland cancer	0.000121	0.000121	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—NUP62—salivary gland cancer	0.00012	0.00012	CbGpPWpGaD
Naloxone—ALB—Metabolism—NUP62—salivary gland cancer	0.000119	0.000119	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—FOXO3—salivary gland cancer	0.000119	0.000119	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—VCAN—salivary gland cancer	0.000119	0.000119	CbGpPWpGaD
Naloxone—ALB—Metabolism—VCAN—salivary gland cancer	0.000118	0.000118	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—HRAS—salivary gland cancer	0.000116	0.000116	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MAP2K2—salivary gland cancer	0.000115	0.000115	CbGpPWpGaD
Naloxone—ALB—Hemostasis—CREBBP—salivary gland cancer	0.000114	0.000114	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PYGB—salivary gland cancer	0.000114	0.000114	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—PIK3CA—salivary gland cancer	0.000111	0.000111	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.00011	0.00011	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—NOTCH1—salivary gland cancer	0.000109	0.000109	CbGpPWpGaD
Naloxone—CREB1—Immune System—PTEN—salivary gland cancer	0.000108	0.000108	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—NOTCH1—salivary gland cancer	0.000108	0.000108	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—NOTCH1—salivary gland cancer	0.000107	0.000107	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000107	0.000107	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000106	0.000106	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—FOXO3—salivary gland cancer	0.000105	0.000105	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—NUP62—salivary gland cancer	0.000104	0.000104	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000104	0.000104	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000104	0.000104	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—VCAN—salivary gland cancer	0.000104	0.000104	CbGpPWpGaD
Naloxone—CREB1—Immune System—EP300—salivary gland cancer	0.000103	0.000103	CbGpPWpGaD
Naloxone—CREB1—Disease—PTEN—salivary gland cancer	9.96e-05	9.96e-05	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	9.86e-05	9.86e-05	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—CREBBP—salivary gland cancer	9.84e-05	9.84e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CREBBP—salivary gland cancer	9.77e-05	9.77e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CREBBP—salivary gland cancer	9.73e-05	9.73e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MAP2K2—salivary gland cancer	9.71e-05	9.71e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—EP300—salivary gland cancer	9.5e-05	9.5e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—CREBBP—salivary gland cancer	9.45e-05	9.45e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NOTCH1—salivary gland cancer	9.41e-05	9.41e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PHGDH—salivary gland cancer	9.28e-05	9.28e-05	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—PIK3CA—salivary gland cancer	9.14e-05	9.14e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	8.93e-05	8.93e-05	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	8.64e-05	8.64e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MAP2K2—salivary gland cancer	8.61e-05	8.61e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CREBBP—salivary gland cancer	8.54e-05	8.54e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—PIK3CA—salivary gland cancer	8.33e-05	8.33e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—PIK3CA—salivary gland cancer	8.3e-05	8.3e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—AQP1—salivary gland cancer	8.11e-05	8.11e-05	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—PIK3CA—salivary gland cancer	8.02e-05	8.02e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NOTCH1—salivary gland cancer	7.96e-05	7.96e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—EP300—salivary gland cancer	7.76e-05	7.76e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—HRAS—salivary gland cancer	7.71e-05	7.71e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—HRAS—salivary gland cancer	7.68e-05	7.68e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—PIK3CA—salivary gland cancer	7.61e-05	7.61e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	7.45e-05	7.45e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	7.41e-05	7.41e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—PIK3CA—salivary gland cancer	7.28e-05	7.28e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CCND1—salivary gland cancer	7.23e-05	7.23e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CREBBP—salivary gland cancer	7.21e-05	7.21e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CCND1—salivary gland cancer	7.2e-05	7.2e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	7.1e-05	7.1e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	7.06e-05	7.06e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NOTCH1—salivary gland cancer	7.05e-05	7.05e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—HRAS—salivary gland cancer	7.04e-05	7.04e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—PIK3CA—salivary gland cancer	7.03e-05	7.03e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—PTEN—salivary gland cancer	6.97e-05	6.97e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—PTEN—salivary gland cancer	6.95e-05	6.95e-05	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—PIK3CA—salivary gland cancer	6.78e-05	6.78e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—PTEN—salivary gland cancer	6.75e-05	6.75e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—HRAS—salivary gland cancer	6.74e-05	6.74e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—EP300—salivary gland cancer	6.65e-05	6.65e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—EP300—salivary gland cancer	6.63e-05	6.63e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—HRAS—salivary gland cancer	6.5e-05	6.5e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—EP300—salivary gland cancer	6.44e-05	6.44e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—NUP62—salivary gland cancer	6.43e-05	6.43e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CREBBP—salivary gland cancer	6.4e-05	6.4e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—VCAN—salivary gland cancer	6.38e-05	6.38e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CCND1—salivary gland cancer	6.32e-05	6.32e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—PIK3CA—salivary gland cancer	6.15e-05	6.15e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PTEN—salivary gland cancer	6.1e-05	6.1e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—EP300—salivary gland cancer	5.81e-05	5.81e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—PIK3CA—salivary gland cancer	5.74e-05	5.74e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—HRAS—salivary gland cancer	5.69e-05	5.69e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TP53—salivary gland cancer	5.55e-05	5.55e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CCND1—salivary gland cancer	5.34e-05	5.34e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—HRAS—salivary gland cancer	5.31e-05	5.31e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	5.26e-05	5.26e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	5.23e-05	5.23e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PTEN—salivary gland cancer	5.15e-05	5.15e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—PIK3CA—salivary gland cancer	4.92e-05	4.92e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—EP300—salivary gland cancer	4.91e-05	4.91e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—PIK3CA—salivary gland cancer	4.9e-05	4.9e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—PIK3CA—salivary gland cancer	4.76e-05	4.76e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TP53—salivary gland cancer	4.76e-05	4.76e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TP53—salivary gland cancer	4.74e-05	4.74e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CCND1—salivary gland cancer	4.73e-05	4.73e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CREBBP—salivary gland cancer	4.65e-05	4.65e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—CREBBP—salivary gland cancer	4.62e-05	4.62e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PTEN—salivary gland cancer	4.57e-05	4.57e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—HRAS—salivary gland cancer	4.55e-05	4.55e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—HRAS—salivary gland cancer	4.54e-05	4.54e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—EP300—salivary gland cancer	4.36e-05	4.36e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PIK3CA—salivary gland cancer	4.3e-05	4.3e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TP53—salivary gland cancer	4.16e-05	4.16e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CREBBP—salivary gland cancer	4.05e-05	4.05e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—HRAS—salivary gland cancer	3.98e-05	3.98e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PIK3CA—salivary gland cancer	3.63e-05	3.63e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TP53—salivary gland cancer	3.52e-05	3.52e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—HRAS—salivary gland cancer	3.36e-05	3.36e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PTEN—salivary gland cancer	3.32e-05	3.32e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—PTEN—salivary gland cancer	3.3e-05	3.3e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PIK3CA—salivary gland cancer	3.22e-05	3.22e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—EP300—salivary gland cancer	3.16e-05	3.16e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—EP300—salivary gland cancer	3.15e-05	3.15e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TP53—salivary gland cancer	3.12e-05	3.12e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—HRAS—salivary gland cancer	2.98e-05	2.98e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PTEN—salivary gland cancer	2.89e-05	2.89e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—EP300—salivary gland cancer	2.76e-05	2.76e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CREBBP—salivary gland cancer	2.49e-05	2.49e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PIK3CA—salivary gland cancer	2.34e-05	2.34e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—PIK3CA—salivary gland cancer	2.33e-05	2.33e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PIK3CA—salivary gland cancer	2.04e-05	2.04e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PTEN—salivary gland cancer	1.78e-05	1.78e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—EP300—salivary gland cancer	1.7e-05	1.7e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	1.26e-05	1.26e-05	CbGpPWpGaD
